Sun, Apr 20, 2014, 6:32 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pacira Pharmaceuticals, Inc. Message Board

  • patchen76 patchen76 Oct 31, 2013 7:53 AM Flag

    20mil for the quarter (???) 1.6billion????

    So next year lets say an average of 35mil per quarter gives 140-150mil annual revs for 2014. I still have a tough time with 1.6 bil even after next year basically doubling revenue from this year. Although they should be profitable next year. Unless they keep spending. Good luck

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • realinvestmentstrategies realinvestmentstrategies Oct 31, 2013 8:46 AM Flag

      At $285 per vile and a potential US market of 40 million annually there is plenty of growth potential.

      We need to know how well EXPAREL is being accepted. Was the sales increase a result of increased usage or just inventory build up by the customers? Will the price be lowered? What percentage of the 40 million annual surgeries actually involve EXPAREL long term.

      This is still a developmental drug company. Hard to tell where EXPAREL will be in five years. But $1.6 billion is a large market cap.

 
PCRX
66.05-1.67(-2.47%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST